{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:21:14Z","timestamp":1784013674493,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90052-w","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:48:47Z","timestamp":1739771327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Excessive lymph node dissection increases postoperative cardiovascular disease risk in non-small cell lung cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Xinyi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"90052_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jtho.2023.01.088","volume":"18","author":"H Asamura","year":"2023","unstructured":"Asamura, H. et al. The new database to inform revisions in the ninth edition of the TNM classification of lung cancer. J. Thorac. Oncol. 18, 564\u2013575. https:\/\/doi.org\/10.1016\/j.jtho.2023.01.088 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"90052_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely, G. J. et al. Non-small cell lung cancer, Version 4.2024, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 22, 249\u2013274. https:\/\/doi.org\/10.6004\/jnccn.2204.0023 (2024).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"90052_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta, R. et al. Proposals for revision of the TNM stage groups in the Forthcoming (Ninth) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 19, 1007\u20131027. https:\/\/doi.org\/10.1016\/j.jtho.2024.02.011 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"90052_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/heartjnl-2022-321888","volume":"109","author":"Z Raisi-Estabragh","year":"2023","unstructured":"Raisi-Estabragh, Z. et al. Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer. Heart 109, 1007\u20131015. https:\/\/doi.org\/10.1136\/heartjnl-2022-321888 (2023).","journal-title":"Heart"},{"key":"90052_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2019.01.01","volume":"31","author":"Health Commission of Prc, N","year":"2019","unstructured":"Health Commission of Prc, N. Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version). Chin. J. Cancer Res. 31, 1\u201328. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.01 (2019).","journal-title":"Chin. J. Cancer Res."},{"key":"90052_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.21037\/tlcr-20-1024","volume":"10","author":"Z Zhu","year":"2021","unstructured":"Zhu, Z. et al. A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer. Transl. Lung Cancer Res. 10, 815\u2013825. https:\/\/doi.org\/10.21037\/tlcr-20-1024 (2021).","journal-title":"Transl. Lung Cancer Res."},{"key":"90052_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/ejcts\/ezaa267","volume":"59","author":"K Nakagawa","year":"2021","unstructured":"Nakagawa, K., Yoshida, Y., Yotsukura, M. & Watanabe, S. I. Pattern of recurrence of pN2 non-small-cell lung cancer: Should postoperative radiotherapy be reconsidered? Eur. J. Cardiothorac. Surg. 59, 109\u2013115. https:\/\/doi.org\/10.1093\/ejcts\/ezaa267 (2021).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"90052_CR8","doi-asserted-by":"publisher","first-page":"203179","DOI":"10.5402\/2011\/203179","volume":"2011","author":"C Chelazzi","year":"2011","unstructured":"Chelazzi, C., Villa, G. & De Gaudio, A. R. Postoperative atrial fibrillation. ISRN Cardiol. 2011, 203179. https:\/\/doi.org\/10.5402\/2011\/203179 (2011).","journal-title":"ISRN Cardiol."},{"key":"90052_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/SLA.0000000000001626","volume":"264","author":"D Cardinale","year":"2016","unstructured":"Cardinale, D. et al. Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: The PRESAGE trial. Ann. Surg. 264, 244\u2013251. https:\/\/doi.org\/10.1097\/SLA.0000000000001626 (2016).","journal-title":"Ann. Surg."},{"key":"90052_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1200\/JCO.2016.67.5140","volume":"35","author":"W Liang","year":"2017","unstructured":"Liang, W. et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: A population study of the US SEER database and a Chinese multi-institutional registry. J. Clin. Oncol. 35, 1162\u20131170. https:\/\/doi.org\/10.1200\/JCO.2016.67.5140 (2017).","journal-title":"J. Clin. Oncol."},{"key":"90052_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JS9.0000000000000774","volume":"110","author":"H Deng","year":"2024","unstructured":"Deng, H. et al. Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: A multi-institutional retrospective cohort study. Int. J. Surg. 110, 238\u2013252. https:\/\/doi.org\/10.1097\/JS9.0000000000000774 (2024).","journal-title":"Int. J. Surg."},{"key":"90052_CR12","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1172\/JCI97192","volume":"128","author":"JM Vieira","year":"2018","unstructured":"Vieira, J. M. et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J. Clin. Invest. 128, 3402\u20133412. https:\/\/doi.org\/10.1172\/JCI97192 (2018).","journal-title":"J. Clin. Invest."},{"key":"90052_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/circresaha.115.306544","volume":"118","author":"A Aspelund","year":"2016","unstructured":"Aspelund, A., Robciuc, M. R., Karaman, S., Makinen, T. & Alitalo, K. Lymphatic system in cardiovascular medicine. Circul. Res. 118, 515\u2013530. https:\/\/doi.org\/10.1161\/circresaha.115.306544 (2016).","journal-title":"Circul. Res."},{"issue":"1","key":"90052_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-5002(01)00445-7","volume":"36","author":"YL Wu","year":"2002","unstructured":"Wu, Y. L., Huang, Z. F., Wang, S. Y., Yang, X. N. & Ou, W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36(1), 1\u20136 (2002).","journal-title":"Lung Cancer"},{"key":"90052_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.athoracsur.2005.02.005","volume":"80","author":"D Lardinois","year":"2005","unstructured":"Lardinois, D. et al. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann. Thorac. Surg. 80, 268\u2013274. https:\/\/doi.org\/10.1016\/j.athoracsur.2005.02.005 (2005). (discussion 274\u2009\u2013\u2009265).","journal-title":"Ann. Thorac. Surg."},{"key":"90052_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jtcvs.2010.11.008","volume":"141","author":"GE Darling","year":"2011","unstructured":"Darling, G. E. et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 trial. J. Thorac. Cardiovasc. Surg. 141, 662\u2013670. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.11.008 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"90052_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jtho.2023.02.010","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Selective mediastinal lymph node dissection strategy for clinical T1N0 invasive lung cancer: A prospective, multicenter, clinical trial. J. Thorac. Oncol. 18, 931\u2013939. https:\/\/doi.org\/10.1016\/j.jtho.2023.02.010 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"90052_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/JTO.0000000000000406","volume":"10","author":"CD Corso","year":"2015","unstructured":"Corso, C. D. et al. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J. Thorac. Oncol. 10, 148\u2013155. https:\/\/doi.org\/10.1097\/JTO.0000000000000406 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"90052_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.lungcan.2013.02.005","volume":"80","author":"S Burdett","year":"2013","unstructured":"Burdett, S., Rydzewska, L., Tierney, J. F., Fisher, D. J. & Group, P. M.-A. T. A closer look at the effects of postoperative radiotherapy by stage and nodal status: Updated results of an individual participant data meta-analysis in non-small-cell lung cancer. Lung Cancer 80, 350\u2013352. https:\/\/doi.org\/10.1016\/j.lungcan.2013.02.005 (2013).","journal-title":"Lung Cancer"},{"key":"90052_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","volume":"23","author":"C Le Pechoux","year":"2022","unstructured":"Le Pechoux, C. et al. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (lung ART): An open-label, randomised, phase 3 trial. Lancet Oncol. 23, 104\u2013114. https:\/\/doi.org\/10.1016\/S1470-2045(21)00606-9 (2022).","journal-title":"Lancet Oncol."},{"key":"90052_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000743","author":"G Song","year":"2024","unstructured":"Song, G. et al. Cardiac lymphatics and therapeutic prospects in cardiovascular disease: New perspectives and hopes. Cardiol. Rev. https:\/\/doi.org\/10.1097\/CRD.0000000000000743 (2024).","journal-title":"Cardiol. Rev."},{"issue":"2","key":"90052_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1213\/00000539-200108000-00003","volume":"93","author":"T Oka","year":"2001","unstructured":"Oka, T. & Ohkubo, O. Y. Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth. Analg. 93(2), 253\u2013259 (2001).","journal-title":"Anesth. Analg."},{"key":"90052_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejcts.2005.01.017","volume":"28","author":"HJ Ahn","year":"2005","unstructured":"Ahn, H. J., Sim, W. S., Shim, Y. M. & Kim, J. A. Thoracic epidural anesthesia does not improve the incidence of arrhythmias after transthoracic esophagectomy. Eur. J. Cardiothorac. Surg. 28, 19\u201321. https:\/\/doi.org\/10.1016\/j.ejcts.2005.01.017 (2005).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"90052_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","volume":"27","author":"CJ Boos","year":"2006","unstructured":"Boos, C. J., Anderson, R. A. & Lip, G. Y. Is atrial fibrillation an inflammatory disorder? Eur. Heart J. 27, 136\u2013149. https:\/\/doi.org\/10.1093\/eurheartj\/ehi645 (2006).","journal-title":"Eur. Heart J."},{"key":"90052_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.jvca.2005.03.026","volume":"20","author":"G Lamm","year":"2006","unstructured":"Lamm, G. et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 20, 51\u201356. https:\/\/doi.org\/10.1053\/j.jvca.2005.03.026 (2006).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"90052_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41586-020-2998-x","volume":"588","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Lymphoangiocrine signals promote cardiac growth and repair. Nature 588, 705\u2013711. https:\/\/doi.org\/10.1038\/s41586-020-2998-x (2020).","journal-title":"Nature"},{"key":"90052_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ejcts\/ezy311","volume":"55","author":"M Chiappetta","year":"2019","unstructured":"Chiappetta, M. et al. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: A multicentre analysisdagger. Eur. J. Cardiothorac. Surg. 55, 405\u2013412. https:\/\/doi.org\/10.1093\/ejcts\/ezy311 (2019).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"90052_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jjco\/hyz120","volume":"50","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Prognostic value of lymph node ratio in non-small-cell lung cancer: A meta-analysis. Jpn. J. Clin. Oncol. 50, 44\u201357. https:\/\/doi.org\/10.1093\/jjco\/hyz120 (2020).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"90052_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"90052_CR30","doi-asserted-by":"publisher","first-page":"e012219","DOI":"10.1161\/JAHA.119.012219","volume":"8","author":"Y Jin","year":"2019","unstructured":"Jin, Y. & Fu, J. Novel insights into the NLRP 3 inflammasome in atherosclerosis. J. Am. Heart Assoc. 8, e012219. https:\/\/doi.org\/10.1161\/JAHA.119.012219 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"90052_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914 (2017).","journal-title":"N. Engl. J. Med."},{"key":"90052_CR32","doi-asserted-by":"publisher","first-page":"e005539","DOI":"10.1136\/jitc-2022-005539","volume":"11","author":"M He","year":"2023","unstructured":"He, M. et al. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. J. Immunother. Cancer. 11, e005539. https:\/\/doi.org\/10.1136\/jitc-2022-005539 (2023).","journal-title":"J. Immunother. Cancer."},{"key":"90052_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","volume":"34","author":"E Felip","year":"2023","unstructured":"Felip, E. et al. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial. Ann. Oncol. 34, 907\u2013919. https:\/\/doi.org\/10.1016\/j.annonc.2023.07.001 (2023).","journal-title":"Ann. Oncol."},{"key":"90052_CR34","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde, P. M. et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N. Engl. J. Med. 386, 1973\u20131985. https:\/\/doi.org\/10.1056\/NEJMoa2202170 (2022).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90052-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:36:13Z","timestamp":1739813773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90052-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90052-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has been approved by the Ethics Committee of Cancer Hospital Affiliated to Shandong First Medical University. Given its retrospective nature, the committee has waived the informed consent requirement for this study. We declare that patients information will be kept confidential and that we adhere to the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"5698"}}